Incyte and Genesis Therapeutics Forge Strategic Collaboration to Accelerate Small Molecule Drug Discovery Using AI

Incyte  and Genesis Therapeutics, Inc. announced  that the companies have entered into a strategic collaboration focused on the researc...

February 21, 2025 | Friday | News
Phanes Therapeutics Doses First Patient in Clinical Trial of Peluntamig (PT217) for Advanced Cancers

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced that the f...

February 20, 2025 | Thursday | News
Navi Medical Technologies' Neonav® ECG Tip Location System Receives FDA 510(k) Clearance for Pediatric Care

Navi Medical Technologies, a medical device company focused on pediatric healthcare innovation, proudly announces that its Neonav® ECG Tip Location Sys...

February 18, 2025 | Tuesday | News
AltaPointe Health Launches Specialized Program to Support Women Battling Substance Use Disorders

 AltaPointe Health, a leading provider of behavioral health services in Alabama, is making strides in addressing substance use disorders among wo...

February 18, 2025 | Tuesday | News
TAHO Pharmaceuticals Announces Positive Preliminary Results for TAH3311, World’s First Oral Resolution Film of Apixaban

TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311, the world's first oral resolution film (ODF) of apixaban. Th...

February 18, 2025 | Tuesday | News
Bristol Myers Squibb BMS Reports Five-Year Data: Sotyktu® Maintains Long-Term Efficacy and Safety in Plaque Psoriasis

 Bristol Myers Squibb announced new five-year results from the POETYK PSO long-term extension (LTE) trial of Sotyktu (deucravacitinib) ...

February 17, 2025 | Monday | News
Theratechnologies Resumes Distribution of EGRIFTA SV® Following FDA Approval to Release Manufactured Batches

Theratechnologies Inc., a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine ...

February 14, 2025 | Friday | News
Akeso’s Bispecific Antibody AK139 Receives IND Acceptance from NMPA for Clinical Trials in Respiratory and Skin Diseases

 Akeso, Inc.  is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China National Medical Products Admi...

February 14, 2025 | Friday | News
Alnylam Pharmaceuticals Reports Strong 2024 Financial Results and Outlines Ambitious 2025 Pipeline Advancements

Alnylam Pharmaceuticals, Inc. the leading RNAi therapeutics company, reported its consolidated financial results for the fourth quarter and full year ...

February 14, 2025 | Friday | News
DAAN Biotherapeutics Signs Exclusive Licensing Agreement with LigaChem Biosciences for Novel Tumor-Targeting Antibody

DAAN Biotherapeutics, a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies, has signed an exclusive licensi...

February 13, 2025 | Thursday | News
Thermo Fisher Scientific Launches Invitrogen™ EVOS™ S1000 Spatial Imaging System

WALTHAM, Mass. Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Invitrogen™ EVOS™ S1000 Spatial Imaging Syste...

February 13, 2025 | Thursday | News
NeuFit Revolutionizes Neurological Rehabilitation with Innovative NEUBIE Device

 NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and therapeutic technolo...

February 06, 2025 | Thursday | News
BD Announces Strategic Plan to Separate Biosciences and Diagnostic Solutions Business to Unlock Value for Shareholders

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced its board of directors has unanimously authoriz...

February 06, 2025 | Thursday | News
Grifols Partners with FcR Therapeutics to Develop Nanobodies for Autoimmune Disease Treatment

Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines,  announced that it is col...

February 05, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close